The primary rationale for dual-hormone systems, which are capable of administering boluses of glucagon in addition to continuous insulin infusion, is that prevention of hypoglycemia is more effective with administration of glucagon than with suspension of insulin delivery. Here, INS is linked to Hypoglycemia.